Evidence map›Paper›PMID 40086064›Full record

Trial reportBlood advances2025

Untangling profiles of postthrombotic syndrome using unsupervised machine learning.

Aaron F J Iding, Vincent Ten Cate, Hugo Ten Cate, Philipp S Wild, Arina J Ten Cate-Hoek

Registry-linked trialAbstract readMulticenter StudyRandomized Controlled Trial
In one paragraph

Trial report in Blood advances, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT01429714 (Individually Tailored Elastic Compression Therapy After Deep Venous Thrombosis in Relation to the Incidence of Post Thrombotic Syndrome, a Randomized Multicenter Trial), which is not on this map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01429714 nacompletednot on this map

Individually Tailored Elastic Compression Therapy After Deep Venous Thrombosis in Relation to the Incidence of Post Thrombotic Syndrome, a Randomized Multicenter Trial

TypeinterventionalSponsorMaastricht University Medical CenterRan2011 to 2017Enrolled865ConditionsPostthrombotic SyndromeArmsIndividually tailored duration of elastic compression therapy, Elastic compression therapy with a standard duration of 24 months
3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Aaron F J IdingThrombosis Expertise Center, Heart and Vascular Center, Maastricht University Medical Center, Maastricht, The Netherlands.ORCID 0000-0003-2880-6850
Vincent Ten CateClinical Epidemiology and Systems Medicine, Center for Thrombosis and Hemostasis, University Medical Center of Johannes Gutenberg University Mainz, Mainz, Germany.
Hugo Ten CateThrombosis Expertise Center, Heart and Vascular Center, Maastricht University Medical Center, Maastricht, The Netherlands.ORCID 0000-0001-7796-4463
Philipp S WildClinical Epidemiology and Systems Medicine, Center for Thrombosis and Hemostasis, University Medical Center of Johannes Gutenberg University Mainz, Mainz, Germany.
Arina J Ten Cate-HoekThrombosis Expertise Center, Heart and Vascular Center, Maastricht University Medical Center, Maastricht, The Netherlands.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

abstractPostthrombotic syndrome (PTS) is a chronic condition that can develop after deep vein thrombosis (DVT) and is diagnosed using the Villalta scale. This study applied unsupervised machine learning to investigate the heterogeneity of PTS among patients and within the Villalta scale. In 818 patients from the IDEAL DVT study, clustering identified 4 clinical profiles: (1) younger patients with provoked DVT, (2) women with joint pain, (3) men with isolated popliteal DVT, and (4) older men with diabetes and femoral vein involvement. Clustering of Villalta items revealed a distinction between signs and symptoms. Sign scores increased with older age, male sex, higher body mass index (BMI), and DVT extent, whereas symptom scores increased with younger age, female sex, higher BMI, and provoked DVT. Residual venous obstruction was significantly associated with the sign score (odds ratio, 1.18 per point) but not the symptom score. Quality of life was related to the symptom score more than the sign score. At 6 months, sign and symptom scores differed significantly across profiles, especially between profile 1 and 4, because the former had most symptoms (41% vs 21% ≥ 3; P < .001), whereas the latter had most signs (18% vs 34% ≥ 3; P = .004]). After 2 years, symptoms decreased in profile 1 but increased in profile 4. Other profiles showed intermediate scores over time. These findings suggest that reappraising the PTS scoring system to distinguish its dimensions would enable more personalized risk prediction and prevention. This trial was registered at www.ClinicalTrials.gov as #NCT01429714.

Indexed as

Postthrombotic SyndromeUnsupervised Machine LearningAdultAgedFemaleHumansMaleMiddle AgedQuality of LifeRisk FactorsVenous Thrombosis

Identifiers

PMID40086064
PMCPMC12302148

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.